Flamma Group

Flamma Group is a family owned and operated Contract Development and Manufacturing Organization (CDMO) that has been advancing amino acids and small molecules since 1950. Headquartered near Milan, Italy, FLAMMA specializes in the cGMP manufacturing of small molecule APIs, NCEs, RSMs, and advanced intermediates, with a particular focus on high-value chiral materials, specifically amino acid-related materials used in peptide drugs. With over 850 employees and a total capacity of 1,100 m3 (900 m3 in Italy and 200 m3 in China), FLAMMA offers a range of manufacturing options, from early-stage pre-clinical development to large-scale commercial manufacturing. The company's 100% owned and self-managed facility in Dalian, China, provides a stable and secure supply chain, enabling FLAMMA to be a preferred supplier to the pharmaceutical and biotech industry. FLAMMA's commitment to providing comprehensive manufacturing solutions throughout the life cycle of small molecule drugs, along with its global presence and expertise, positions it as an attractive investment opportunity. With a strong track record and a focus on innovation, FLAMMA is poised to continue its success as a leading CDMO in the biotechnology, manufacturing, and pharmaceutical industries. Follow FLAMMA to stay updated with the latest developments in the field of Contract Development and Manufacturing: The Thinking CDMO™ - www.flammagroup.com.